N

Nurix Therapeutics

Drug discovery targeting ubiquitin E3 ligases

Director – Nonclinical Toxicology Operations

Program ManagementConfirmed live in the last 24 hours
Full-timeBrisbane, CA, USA$220.7k - $252.7k

About the Job

Requirements

  • An M.S. or Ph.D. in a life sciences discipline such as toxicology, pharmacology, biology, chemistry, or pharmaceutical sciences.
  • Typically 10+ years of relevant biotech or pharmaceutical experience, including demonstrable project management ownership of multidisciplinary programs.
  • A track record managing CROs and external vendors, including contracting, budget tracking, and performance management.
  • Direct experience supporting and coordinating IND-enabling activities.
  • Working knowledge of small molecule drug discovery and development, nonclinical safety assessment, and GLP requirements sufficient to plan, question, and integrate the work.
  • Proficiency with project management tools and methods, including integrated timelines, critical path analysis, and resource planning; tools may include MS Project, Smartsheet, Planisware, or equivalent.
  • Ability to influence and drive accountability without direct authority across a group of senior, highly experienced scientists.
  • Comfort with ambiguity and shifting priorities in a fast-moving discovery environment.
  • Strong team orientation and collaboration.
  • A solutions- and results-oriented focus.
  • A hands-on, resourceful approach and openness to diverse points of view.

Responsibilities

  • Partner with Toxicology Leads and Study Directors to scope, design, and schedule GLP and non-GLP in vivo and in vitro safety studies, including exploratory toxicology, dose-range finding, GLP repeat-dose toxicology, safety pharmacology, and genetic toxicology.
  • Identify, qualify, and manage CROs and specialty vendors; coordinate bid solicitation, bid defense, and vendor selection in partnership with Toxicology, Procurement, and Legal.
  • Own the contract lifecycle by drafting and routing work orders, master service agreements, change orders, and amendments; track scope changes against budget; reconcile invoices; and support accruals and forecasting.
  • Build and maintain integrated study timelines; monitor study milestones, sample logistics, bioanalytical turnaround, and report delivery; and escalate slippage early with options.
  • Coordinate protocol and report review cycles, ensuring documents move efficiently through internal review, quality assurance, and sign-off.
  • Track deliverables required for regulatory submissions, including study reports, certificates of analysis, and test article documentation.
  • Ensure safety issues are communicated rapidly and appropriately escalated to the drug safety/project team, leadership, and relevant agencies.
  • Serve as project manager for assigned discovery and development programs from late lead optimization through candidate selection, IND-enabling studies, and IND filing.
  • Develop and maintain integrated program plans, critical paths, and resource views spanning medicinal chemistry, analytical chemistry, computational chemistry, DMPK, pharmacology, toxicology, CMC, and regulatory.
  • Run project team meetings by setting agendas, capturing actions and decision rationale in meeting minutes, and following through to closure.
  • Maintain program dashboards, milestone trackers, and risk registers; surface risks with mitigation and contingency plans.
  • Prepare materials and pre-reads for portfolio reviews, governance meetings, and leadership updates; ensure a single, consistent version of program status.
  • Coordinate scenario and what-if planning to support go/no-go decisions, candidate selection, and IND timing.
  • Act as a connective hub across functions and sites, resolving interface issues before they become timeline issues.
  • Contribute to continuous improvement of project management practices, templates, and tools within the group.

Desired Qualifications

  • A formal project management credential such as PMP.
  • Experience in targeted protein degradation, oncology, or immunology.
  • Familiarity with AI tools.

About the Company

Nurix Therapeutics

Drug discovery targeting ubiquitin E3 ligases

Nurix Therapeutics develops drugs that use the body's own protein-degradation system to treat diseases. Its core approach is to control ubiquitin E3 ligases, enzymes that tag unwanted proteins for breakdown in cells. By modulating these ligases, Nurix aims to create therapeutics, especially small-molecule immuno-oncology agents, that can selectively remove disease-related proteins in cancer and other serious conditions. The company operates by discovering and developing drug candidates and earning revenue through partnerships, licensing, and potential future sales of its medicines. Unlike many biotech firms that target single proteins, Nurix focuses on the protein-degradation pathway to influence multiple disease processes through carefully designed molecules. The goal is to bring new cancer treatments and other therapies to patients by advancing its degrader-based drugs through research, collaboration, and development toward commercial use.

Company size
201-500
Company stage
IPO
Headquarters
Brisbane, CA
Founded
2012

Recently Posted Jobs

Explore more opportunities at Nurix Therapeutics

See more jobs